Lili Wang, M.D., Ph.D., has joined City of Hope as an associate professor in the Department of Systems Biology. She comes to City of Hope from Harvard Medical School in Boston, where she was an instructor in the Department of Medical Oncology at Dana-Farber Cancer Institute.
Dr. Wang received her Ph.D. in immunology from Tokai University in Japan under mentorship of Dr. Sonoko Habu. She continued her scientific training at the University of Illinois at Chicago in Amy Kenter’s laboratory, and at Dana-Farber Cancer Institute in the laboratory of Catherine Wu, M.D. Her research focuses on the genetics of chronic lymphocytic leukemia (CLL).
Dr. Wang published landmark papers in prestigious journals including New England Journal of Medicine and Cancer Cell. She is the recipient of several awards and has recently received her first R01 grant from the National Cancer Institute to study mouse models of B cell CLL with a focus on the splicing factor SF3B1. She is frequently invited to present her work at national and international conferences and holds several memberships in professional societies including the American Society of Hematology and American Society of Cancer Research.
In the Department of Systems Biology, she will expand her research program to systematically study RNA splicing dysregulation and oncogenesis.